作者：
Alexis,Moscoso [1]
;
Michel J,Grothe [2]
;
Nicholas J,Ashton [1]
;
Thomas K,Karikari [2]
;
Juan Lantero,Rodriguez [3]
;
Anniina,Snellman [1]
;
Marc,Suárez-Calvet [2]
;
Henrik,Zetterberg [4]
;
Kaj,Blennow [5]
;
Michael,Schöll [1]
;
Alzheimer’s Disease Neuroimaging Initiative [1]
作者单位：
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden.
[1]
Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden.
[2]
Unidad de Trastornos del Movimiento, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
[3]
King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK.
[4]
NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK.
[5]
Turku PET Centre, University of Turku, FI-20520 Turku, Finland.
[6]
Barcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
[7]
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
[8]
Servei de Neurologia, Hospital del Mar, Barcelona, Spain.
[9]
Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
[10]
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
[11]
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.
[12]
UK Dementia Research Institute at University College London, London, UK.
[13]
DOI
10.1093/brain/awaa399
PMID
33257949
发布时间
2021-07-29
换一批
换一批
